Atwater Malick’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$321K Buy
3,791
+487
+15% +$39.1K 0.07% 96
2026
Q1
$277K Hold
3,304
0.07% 81
2025
Q4
$221K Hold
3,304
0.06% 83
2025
Q3
$223K Hold
3,304
0.06% 78
2025
Q2
$246K Hold
3,304
0.08% 75
2025
Q1
$208K Buy
+3,304
New +$204K 0.07% 75
2022
Q2
Sell
-3,729
Closed -$214K 55
2022
Q1
$214K Buy
+3,729
New +$191K 0.1% 55
2019
Q4
Sell
-3,857
Closed -$108K 79
2019
Q3
$108K Buy
+3,857
New +$112K 0.09% 48

Other funds holding CTVA

Atwater Malick's CTVA Position: Q2 2026 in Review

Atwater Malick increased its Corteva (CTVA) stake by 15% in Q2 2026, buying an estimated $39.1K and bringing the position to 3,791 shares worth $321K. The position accounts for 0.07% of the portfolio, ranked #96.

Atwater Malick first reported a position in CTVA in Q3 2019 and has held it in 8 quarters since. 1,491 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Atwater Malick held 3,791 shares of Corteva worth $321K as of Q2 2026.
  • Atwater Malick bought 487 Corteva shares in Q2 2026, an estimated $39.1K.
  • Corteva made up 0.07% of Atwater Malick's portfolio in Q2 2026, its #96 holding.
  • Atwater Malick first reported a position in Corteva in Q3 2019 and has held it in 8 quarters since.
  • 1,491 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Atwater Malick's 13F filing for Q2 2026, filed 27 Jul 2026.